Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate ‐to‐severe plaque psoriasis

Biopharmaceutics&Drug Disposition,Volume 39, Issue 5, Page 245-255, May 2018.
Source: Biopharmaceutics and Drug Disposition - Category: Drugs & Pharmacology Authors: Source Type: research